# FDA Inspection 1204167 - Amgen Europe BV - May 03, 2022

Source: https://www.keypedia.com/records/fda_inspections/amgen-europe-bv/21984314-cf0b-4390-b27b-d5d1d39a2830
Source feed: FDA_Inspections

> FDA Inspection 1204167 for Amgen Europe BV on May 03, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204167
- Company Name: Amgen Europe BV
- Inspection Date: 2022-05-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1041358 - 2018-01-11](https://www.keypedia.com/records/fda_inspections/amgen-europe-bv/71c927c5-14af-4b0b-8b9c-f17966266420)

Company: https://www.keypedia.com/companies/amgen-europe-bv/869a9ce4-c741-4aec-b25c-d68d881594a7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c